50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today AXDX ranks #10016 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Accelerate Diagnostics Stock Forecast NASDAQ:AXDX

$5.00 (-8.93%)

Volume: 235k

Closed: Nov 26, 2021

Hollow Logo Score: -2.950

Accelerate Diagnostics Stock Forecast

$5.00 (-8.93%)

Volume: 235k

Closed: Nov 26, 2021

Score Hollow Logo -2.950
Which way will AXDX go? Request
Key Stats
Beta 0.77
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 35 and the stock is currently not being overbought or oversold

Accelerate Diagnostics stock price took a fall of -8.93% on Friday
(Updated on Nov 26, 2021)

Sell candidate since 2021-11-24 Loss -8.93%

The Accelerate Diagnostics stock price fell by -8.93% on the last day (Friday, 26th Nov 2021) from $5.49 to $5.00. During the day the stock fluctuated 7.20% from a day low at $5.00 to a day high of $5.36. The price has fallen in 7 of the last 10 days and is down by -19.35% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -391 thousand shares and in total, 235 thousand shares were bought and sold for approximately $1.17 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($5.17) are considered to be a "second chance" to get out. According to the fan-theory $3.40 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Signals & Forecast

There are few to no technical positive signals at the moment. The Accelerate Diagnostics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.23 and $6.02. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, November 12, 2021, and so far it has fallen -28.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.36 between high and low, or 7.20%. For the last week the stock has had a daily average volatility of 5.54%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Accelerate Diagnostics stock A Buy?

Accelerate Diagnostics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.950

Predicted Opening Price for Accelerate Diagnostics of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$5.12 $5.00 (Undervalued)
Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

Piper Sandler is very positive about AXDX and gave it a "Overweight" rating on May 10, 2021. The price target was changed from $12.00 to $9.00.

Volatility and Risk
Daily Average Volatility: 5.54 %
Overall Risk: Very High High Medium Low Very Low
5.54 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $6.05
Price: $5.00
No Support Found

AXDX Insider Trading Show all Trades



Last 100 transactions
Buy: 4 515 199 | Sell: 517 455 (Shares)
Date Action Amount Person Type
Nov 22, 2021 Buy 48 987 Schuler Jack W Common Stock
Nov 19, 2021 Buy 56 850 Schuler Jack W Common Stock
Nov 18, 2021 Buy 116 444 Schuler Jack W Common Stock
Sep 28, 2021 Buy 59 978 Schuler Jack W Common Stock
Sep 27, 2021 Buy 150 000 Schuler Jack W Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 4 515 199 | Sell: 517 455 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 5.48 9.60 %
5.34 6.85 %
5.26 5.15 %
Current price: 5.00
Support 4.98 -0.35 %
4.90 -2.05 %
4.76 -4.80 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 6.23 24.60 %
6.20 24.00 %
6.05 21.00 %
Current price 5.00
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Accelerate Diagnostics

Accelerate Diagnostics Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. It offers ID/AST System, a rapid diagnostic platform for the diagnosis of infectious pathogens. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in T... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE